Therapy Areas
OncoNews
Lung Cancer
Women's Cancers
Urogenital
Gastro-intestinal
Hematology
Other Tumors
Videos
Jul
10
2025
Hosted On
Targeted Therapies 2025
LUNGSUMMIT.ORG
Jun
25
2025
Hosted On
Immunotherapies in NSCLC
LUNGSUMMIT.ORG
Jun
17
2025
Hosted On
SCLC 2025
LUNGSUMMIT.ORG
Dec
17
2024
Lung Cancer
Lung Cancer 2024 REVIEW
1 h 43 min
Nov
26
2024
Lung Cancer
EARLY NSCLC
1 h 37 min
Nov
06
2024
Antibody Drug Conjugates
Antibody Drug Conjugates
1 h 39 min
Jun
12
2024
Lung Cancer
Lung Cancer (ASCO 2024)
1 h 32 min
Apr
30
2024
Biomarkers
HER2 in Lung, GYNE & GI Cancers
1 h 34 min
Feb
06
2024
Biomarkers
Biomarkers in GI & Lung
1 h 45 min
Jan
24
2024
Lung Cancer
Early NSCLC
1 h 30 min
Articles
Anne Schultheis
Apr
10
2025
Biomarkers, Lung Cancer
Diagnosis of Lung Cancer: Biomarker Testing on the Road to the Future
EMA Approval
Feb
03
2025
Lung Cancer, Women's Cancers
CHMP Recommends Approval of Three Promising Therapies in the EU
Nuria María Novoa
Jan
29
2025
Lung Cancer
Surgical Treatment of Lung Cancer: Defining Resectability in the Immunotherapy Era
PEAK Medicals
Jan
09
2025
Lung Cancer
Debate: Continuous Vs. Fixed-duration Immunotherapy
FDA Approval
Dec
05
2024
Lung Cancer
FDA Approves New Therapies For NSCLC and SCLC
Swiss Approval
Oct
11
2024
Lung Cancer
Swissmedic Approves Osimertinib for Locally Advanced EGFR-Positive NSCLC
EMA Approval
Aug
30
2024
Lung Cancer, Urogenital
European Commission Approves New Treatments for Urothelial and Lung Cancer
PEAK Medicals
Aug
01
2024
Lung Cancer
Celebrating Breakthroughs in Lung Cancer Treatment on World Lung Cancer Day
Swiss Approval
Jul
26
2024
Lung Cancer
Swissmedic Approves Alectinib In Early Stage ALK+ NSCLC
Swiss Approval
Jul
04
2024
Lung Cancer